Moomoo AI 已提取核心信息
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive...Show More
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have collectively filed a Schedule 13G with the United States Securities and Exchange Commission (SEC) on February 14, 2024, indicating a shared voting and dispositive power over 6,912,502 shares of bluebird bio, Inc. This represents 6.32% of the company's common stock. The filing, which is required due to the event date of December 31, 2023, signifies that the reporting persons have crossed the threshold of beneficial ownership that necessitates disclosure under the Securities Exchange Act of 1934. The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The principal business office for all reporting persons is located at 77 West Wacker Drive, 7th Floor, Chicago, IL 60601. Alyeska Investment Group, L.P. and Alyeska Fund GP, LLC are organized in Delaware, while Anand Parekh is a citizen of the United States of America. The filing indicates that Alyeska Investment Group, L.P. is an investment adviser and a parent holding company or control person as per the SEC rules.
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC和Anand Parekh于2024年2月14日共同向美国证券交易委员会（SEC）提交了附表13G，表示对蓝鸟生物公司的6,912,502股股票拥有共同投票权和处置权。这占该公司普通股的6.32％。由于事件发生日期为2023年12月31日，因此必须提交该文件，这表明申报人已经跨越了1934年《证券交易法》规定的受益所有权门槛，因此必须进行披露。这些股份是在正常业务过程中持有的，不是为了改变或影响发行人的控制权。所有举报人的主要业务办公室位于伊利诺伊州芝加哥市西瓦克大道77号7楼60601。Al...展开全部
Alyeska Investment Group, L.P.、Alyeska Fund GP, LLC和Anand Parekh于2024年2月14日共同向美国证券交易委员会（SEC）提交了附表13G，表示对蓝鸟生物公司的6,912,502股股票拥有共同投票权和处置权。这占该公司普通股的6.32％。由于事件发生日期为2023年12月31日，因此必须提交该文件，这表明申报人已经跨越了1934年《证券交易法》规定的受益所有权门槛，因此必须进行披露。这些股份是在正常业务过程中持有的，不是为了改变或影响发行人的控制权。所有举报人的主要业务办公室位于伊利诺伊州芝加哥市西瓦克大道77号7楼60601。Alyeska Investment Group, L.P. 和 Alyeska Fund GP, LLC在特拉华州成立，而阿南德·帕雷克是美利坚合众国公民。该文件显示，根据美国证券交易委员会的规定，Alyeska Investment Group, L.P. 是一家投资顾问和母控股公司或控股人。
有用
没用